Jun 22, 2021 / 12:00PM GMT
Operator
Good morning and welcome to Intellia Therapeutics Corporate Update Call. (Operator Instructions) Please be advised, this conference call is being recorded at the company's request.
I will now turn the conference over to Lina Li, Director of Investor Relations at Intellia. Please proceed.
Lina Li - Intellia Therapeutics, Inc. - Director of IR
Thank you, operator, and good morning, everyone.
Welcome to Intellia's corporate update call to discuss the establishment of a new universal CAR-T company. Earlier this morning, Intellia issued a joint press release with Blackstone Life Sciences and Cellex Cell Professionals detailing the terms of the venture. This release can be found on the Investors & Media section of Intellia's website at intelliatx.com. As a reminder, this call is being broadcast live and a replay will also be archived on the company's website.
Joining me on the call today are Dr. John Leonard, Chief Executive Officer; Dr. David Lebwohl, Chief Medical Officer; Dr. Laura Sepp-Lorenzino, Chief Scientific Officer; and Glenn
Intellia Therapeutics Inc Launch of New Universal CAR-T Company with Cellex and Blackstone Life Sciences Corporate Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
